Medicare Enrolled
Dr. Mehrdad Asgeri, MD
Gastroenterology · Palm Springs, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Asgeri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Asgeri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Asgeri
Dr. Mehrdad Asgeri is a gastroenterology specialist in Palm Springs, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Asgeri performed 2,052 Medicare services across 1,866 unique beneficiaries.
Between the years covered by Open Payments, Dr. Asgeri received a total of $5,579 from 38 pharmaceutical and/or device companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Asgeri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in CA
$5,579 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,052
Medicare services
Top 9% in CA for gastroenterology
1,866
Unique beneficiaries
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~108 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
329 | $96 | $251 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
322 | $122 | $250 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
266 | $80 | $576 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
214 | $146 | $350 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
196 | $108 | $585 |
| New patient office visit, complex (60-74 min) | 192 | $175 | $350 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
151 | $204 | $800 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
108 | $138 | $350 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
48 | $151 | $591 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
38 | $185 | $454 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
32 | $130 | $600 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
23 | $20 | $765 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $64 | $150 |
| Radiologist review of bile duct tube placement imaging A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope. |
21 | $19 | $300 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
19 | $129 | $679 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
15 | $639 | $1,500 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
14 | $75 | $200 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
14 | $10 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $73 | $164 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
13 | $26 | $96 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,579
Total received (2018-2024)
Avg $797/year across 7 years
Top 28% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,554 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,419
2023
$1,063
2022
$514
2021
$957
2020
$389
2019
$412
2018
$824
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$296
Phathom Pharmaceuticals, Inc.
$206
Ardelyx, Inc.
$171
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$155
Ferring Pharmaceuticals Inc.
$116
Madrigal Pharmaceuticals
$107
GENZYME CORPORATION
$61
Merck Sharp & Dohme LLC
$58
PFIZER INC.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$43
Gilead Sciences, Inc.
$27
Echosens North America, Inc.
$24
Intercept Pharmaceuticals, Inc.
$24
Braintree Laboratories, Inc.
$22
Celltrion USA Inc.
$21
Celgene Corporation
$21
AIMMUNE THERAPEUTICS, INC.
$14
Top 3 companies account for 47.4% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$846
PENTAX of America, Inc.
$639
ABBVIE INC.
$555
AbbVie Inc.
$520
Ardelyx, Inc.
$390
RedHill Biopharma Inc.
$246
Phathom Pharmaceuticals, Inc.
$221
AbbVie, Inc.
$174
Takeda Pharmaceuticals U.S.A., Inc.
$163
Celgene Corporation
$159
Merck Sharp & Dohme LLC
$157
Ferring Pharmaceuticals Inc.
$146
Abbott Laboratories
$134
Nestle HealthCare Nutrition Inc.
$133
Pernix Therapeutics Holdings, Inc.
$125
Janssen Scientific Affairs, LLC
$125
Madrigal Pharmaceuticals
$107
GENZYME CORPORATION
$97
Merck Sharp & Dohme Corporation
$65
Janssen Biotech, Inc.
$61
PFIZER INC.
$54
Regeneron Healthcare Solutions, Inc.
$51
Gilead Sciences, Inc.
$49
Boston Scientific Corporation
$44
INTERCEPT PHARMACEUTICALS, INC.
$37
CONMED Corporation
$33
IRONWOOD PHARMACEUTICALS, INC
$27
AMAG Pharmaceuticals, Inc.
$24
Echosens North America, Inc.
$24
Intercept Pharmaceuticals, Inc.
$24
Braintree Laboratories, Inc.
$22
Celltrion USA Inc.
$21
Shionogi Inc
$21
Ironwood Pharmaceuticals, Inc
$20
Exact Sciences Corporation
$19
AngioDynamics, Inc.
$17
Alfasigma USA, Inc.
$15
AIMMUNE THERAPEUTICS, INC.
$14
Top 3 companies account for 36.6% of all-time payments
Associated products mentioned in payments ›
Aemcolo · CONMED BILIARY · CREON · CapsoCam · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · ENTYVIO · FERAHEME · FibroScan · Humira · IBSRELA · LINZESS · Linzess · MAVYRET · Mavyret · Movantik · Mulpleta · OCALIVA · Proclaim Family of SCS IPGs · REBYOTA · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUFLAVE · Slim Linear · TRULANCE · Talicia · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · WALLFLEX · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZOHYDRO ER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
25
Per 100K population
1.0
County median income
$89,672
Nearest hospital
DESERT REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Asgeri is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Asgeri experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Asgeri performed 329 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Asgeri receive payments from pharmaceutical companies?
Yes. Dr. Asgeri received a total of $5,579 from 38 companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Asgeri's costs compare to other gastroenterologists in Palm Springs?
Dr. Asgeri's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Asgeri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Palm Springs
Browse gastroenterologists in Palm Springs ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
PENTAX of America, Inc. Payments to Doctors
See all physicians who received payments from PENTAX of America, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology